Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00PXQ
|
||||
Former ID |
DPR000043
|
||||
Drug Name |
Fananserin
|
||||
Synonyms |
RP 62203; Fananserin [USAN:INN]; RP-62203; Fananserin (USAN/INN); 2-(3-(4-(4-fluorophenyl)-1-piperazinyl)propyl)-2H-naphth(1,8-cd)isothiazole 1,1-dioxide; 2-(3-(4-(p-Fluorophenyl)-1-piperazinyl)propyl)-2H-naphth(1,8-cd)isothiazole 1,1-dioxide; 2H-Naphth(1,8-cd)isothiazole, 2-(3-(4-(4-fluorophenyl)-1-piperazinyl)propyl)-, 1,1-dioxide
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H24FN3O2S
|
||||
InChI |
InChI=1S/C23H24FN3O2S/c24-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-3-13-27-21-6-1-4-18-5-2-7-22(23(18)21)30(27,28)29/h1-2,4-11H,3,12-17H2
|
||||
InChIKey |
VGIGHGMPMUCLIQ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 127625-29-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
8187052, 14856245, 43118132, 47205811, 50064308, 50112947, 57314111, 78566174, 85212007, 85788217, 103922972, 104321638, 129471014, 134339513, 135018988, 135698206, 137237442, 140010545, 140173976, 144206140, 160703995, 162023484, 163124146, 170466120, 178100286, 178102086, 179149761, 198976575, 204372620, 224932293, 226676066, 241376050, 249617645, 250071166, 252156679
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Antagonist | [536463] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References | |||||
Ref 536463 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. | ||||
Ref 540837 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5434). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.